Phosphatidylserine-targeted nanotheranostics for brain tumor imaging and therapeutic potential

Lulu Wang, Amyn A. Habib, Akiva Mintz, King C. Li, Dawen Zhao

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Phosphatidylserine (PS), the most abundant anionic phospholipid in cell membrane, is strictly confined to the inner leaflet in normal cells. However, this PS asymmetry is found disruptive in many tumor vascular endothelial cells. We discuss the underlying mechanisms for PS asymmetry maintenance in normal cells and its loss in tumor cells. The specificity of PS exposure in tumor vasculature but not normal blood vessels may establish it a useful biomarker for cancer molecular imaging. Indeed, utilizing PS-targeting antibodies, multiple imaging probes have been developed and multimodal imaging data have shown their high tumor-selective targeting in various cancers. There is a critical need for improved diagnosis and therapy for brain tumors. We have recently established PS-targeted nanoplatforms, aiming to enhance delivery of imaging contrast agents across the blood-brain barrier to facilitate imaging of brain tumors. Advantages of using the nanodelivery system, in particular, lipid-based nanocarriers, are discussed here. We also describe our recent research interest in developing PS-targeted nanotheranostics for potential image-guided drug delivery to treat brain tumors.

Original languageEnglish (US)
JournalMolecular Imaging
Volume16
DOIs
StatePublished - 2017

Fingerprint

Phosphatidylserines
Neuroimaging
Brain Neoplasms
brain
Tumors
Brain
tumors
Imaging techniques
Neoplasms
Therapeutics
delivery
cancer
Multimodal Imaging
asymmetry
blood-brain barrier
Molecular imaging
Molecular Imaging
biomarkers
blood vessels
Phospholipids

Keywords

  • Blood-brain barrier (BBB)
  • Brain tumor
  • Molecular imaging
  • Nanotheranostics
  • Phosphatidylserine (PS)

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging
  • Condensed Matter Physics

Cite this

Phosphatidylserine-targeted nanotheranostics for brain tumor imaging and therapeutic potential. / Wang, Lulu; Habib, Amyn A.; Mintz, Akiva; Li, King C.; Zhao, Dawen.

In: Molecular Imaging, Vol. 16, 2017.

Research output: Contribution to journalReview article

@article{3348d4fa28b3400eab0548976bf539e6,
title = "Phosphatidylserine-targeted nanotheranostics for brain tumor imaging and therapeutic potential",
abstract = "Phosphatidylserine (PS), the most abundant anionic phospholipid in cell membrane, is strictly confined to the inner leaflet in normal cells. However, this PS asymmetry is found disruptive in many tumor vascular endothelial cells. We discuss the underlying mechanisms for PS asymmetry maintenance in normal cells and its loss in tumor cells. The specificity of PS exposure in tumor vasculature but not normal blood vessels may establish it a useful biomarker for cancer molecular imaging. Indeed, utilizing PS-targeting antibodies, multiple imaging probes have been developed and multimodal imaging data have shown their high tumor-selective targeting in various cancers. There is a critical need for improved diagnosis and therapy for brain tumors. We have recently established PS-targeted nanoplatforms, aiming to enhance delivery of imaging contrast agents across the blood-brain barrier to facilitate imaging of brain tumors. Advantages of using the nanodelivery system, in particular, lipid-based nanocarriers, are discussed here. We also describe our recent research interest in developing PS-targeted nanotheranostics for potential image-guided drug delivery to treat brain tumors.",
keywords = "Blood-brain barrier (BBB), Brain tumor, Molecular imaging, Nanotheranostics, Phosphatidylserine (PS)",
author = "Lulu Wang and Habib, {Amyn A.} and Akiva Mintz and Li, {King C.} and Dawen Zhao",
year = "2017",
doi = "10.1177/1536012117708722",
language = "English (US)",
volume = "16",
journal = "Molecular Imaging",
issn = "1535-3508",
publisher = "Decker Publishing",

}

TY - JOUR

T1 - Phosphatidylserine-targeted nanotheranostics for brain tumor imaging and therapeutic potential

AU - Wang, Lulu

AU - Habib, Amyn A.

AU - Mintz, Akiva

AU - Li, King C.

AU - Zhao, Dawen

PY - 2017

Y1 - 2017

N2 - Phosphatidylserine (PS), the most abundant anionic phospholipid in cell membrane, is strictly confined to the inner leaflet in normal cells. However, this PS asymmetry is found disruptive in many tumor vascular endothelial cells. We discuss the underlying mechanisms for PS asymmetry maintenance in normal cells and its loss in tumor cells. The specificity of PS exposure in tumor vasculature but not normal blood vessels may establish it a useful biomarker for cancer molecular imaging. Indeed, utilizing PS-targeting antibodies, multiple imaging probes have been developed and multimodal imaging data have shown their high tumor-selective targeting in various cancers. There is a critical need for improved diagnosis and therapy for brain tumors. We have recently established PS-targeted nanoplatforms, aiming to enhance delivery of imaging contrast agents across the blood-brain barrier to facilitate imaging of brain tumors. Advantages of using the nanodelivery system, in particular, lipid-based nanocarriers, are discussed here. We also describe our recent research interest in developing PS-targeted nanotheranostics for potential image-guided drug delivery to treat brain tumors.

AB - Phosphatidylserine (PS), the most abundant anionic phospholipid in cell membrane, is strictly confined to the inner leaflet in normal cells. However, this PS asymmetry is found disruptive in many tumor vascular endothelial cells. We discuss the underlying mechanisms for PS asymmetry maintenance in normal cells and its loss in tumor cells. The specificity of PS exposure in tumor vasculature but not normal blood vessels may establish it a useful biomarker for cancer molecular imaging. Indeed, utilizing PS-targeting antibodies, multiple imaging probes have been developed and multimodal imaging data have shown their high tumor-selective targeting in various cancers. There is a critical need for improved diagnosis and therapy for brain tumors. We have recently established PS-targeted nanoplatforms, aiming to enhance delivery of imaging contrast agents across the blood-brain barrier to facilitate imaging of brain tumors. Advantages of using the nanodelivery system, in particular, lipid-based nanocarriers, are discussed here. We also describe our recent research interest in developing PS-targeted nanotheranostics for potential image-guided drug delivery to treat brain tumors.

KW - Blood-brain barrier (BBB)

KW - Brain tumor

KW - Molecular imaging

KW - Nanotheranostics

KW - Phosphatidylserine (PS)

UR - http://www.scopus.com/inward/record.url?scp=85033458105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033458105&partnerID=8YFLogxK

U2 - 10.1177/1536012117708722

DO - 10.1177/1536012117708722

M3 - Review article

C2 - 28654387

AN - SCOPUS:85033458105

VL - 16

JO - Molecular Imaging

JF - Molecular Imaging

SN - 1535-3508

ER -